Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2013-09-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2013-2012PMID 24001750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.

  2012cited by this paper
• Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment

  2012cited by this paper
• Nutritional phases in Prader–Willi syndrome

  2011cited by this paper
• Assessment of body composition using bioelectrical impedance analysis in Prader-Willi syndrome.

  2011cited by this paper
• Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

  2010cited by this paper
• Long‐term effects of growth hormone therapy on patients with Prader–Willi syndrome

  2010cited by this paper
• The transition between the phenotypes of Prader–Willi syndrome during infancy and early childhood

  2010cited by this paper
• The transition between the phenotypes of Prader‐Willi syndrome during infancy and early childhood

  2010cited by this paper
• Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.

  2010cited by this paper
• Effects on Growth and Metabolism of Growth Hormone Treatment for 3 Years in 36 Children with Prader-Willi Syndrome

  2010influential reference
• Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

  2009cited by this paper
• Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.

  2009cited by this paper
• High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome.

  2008cited by this paper
• Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader–Willi syndrome

  2008influential reference
• Recommendations for the diagnosis and management of Prader-Willi syndrome.

  2008cited by this paper
• Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader–Willi syndrome

  2008cited by this paper
• Growth Hormone Treatment Completely Normalizes Adult Height and Improves Body Composition in Prader-Willi Syndrome: Experience from KIGS (Pfizer International Growth Database)

  2008cited by this paper
• Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.

  2007cited by this paper
• Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.

  2006cited by this paper
• Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders

  2004cited by this paper
• Use and abuse of HOMA modeling.

  2004cited by this paper
• The intra- and inter-instrument reliability of DXA based on ex vivo soft tissue measurements.

  2004cited by this paper
• Carbohydrate Metabolism Is Not Impaired after 3 Years of Growth Hormone Therapy in Children with Prader-Willi Syndrome

  2003cited by this paper
• Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.

  2002influential reference
• Body index measurements in 1996–7 compared with 1980

  2000cited by this paper
• Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome

  2000cited by this paper
• Spontaneous growth in German children and adolescents with genetically confirmed Prader‐Willi syndrome

  2000influential reference
• Continuing Positive Secular Growth Change in the Netherlands 1955–1997

  2000cited by this paper
• Prader-Willi and Angelman syndromes: sister imprinted disorders.

  2000cited by this paper
• Five years of growth hormone treatment in children with Prader‐Willi syndrome

  1999cited by this paper
• Prader-Willi syndrome, diabetes mellitus and hypogonadism.

  1999cited by this paper
• Plasma Levels of Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein-3 in the Evaluation of Childhood Growth Hormone Deficiency

  1998cited by this paper
• Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents.

  1997cited by this paper
• Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.

  1995cited by this paper
• Prader-Willi syndrome: consensus diagnostic criteria.

  1993cited by this paper
• Blood pressure nomograms for children and adolescents, by height, sex, and age, in the United States

  1993cited by this paper
• PRADER‐WILLI SYNDROME IN A SWEDISH RURAL COUNTY: EPIDEMIOLOGICAL ASPECTS

  1991cited by this paper
• Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

  1976cited by this paper
• Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter.

  1956cited by this paper
• Radiographic Atlas of Skeletal Development of the Hand and Wrist

  1950cited by this paper

• Understanding the burden of endocrine and metabolic disorders in Prader-Willi syndrome: data from the Italian registry.

  2026cites this paper
• Assessment of Nutrition Quality in People With Prader-Willi Syndrome in Australia.

  2026cites this paper
• A contemporary treatment regimen normalizes muscle mass and adult height in children with Prader-Willi syndrome - a longitudinal analysis

  2025cites this paper
• Early-onset growth hormone treatment in Prader–Willi syndrome attenuates transition to severe obesity

  2025cites this paper
• Long-term growth hormone effects in Prader-Willi syndrome

  2025cites this paper
• Efficacy of Human Recombinant Growth Hormone in Females of a Non-Obese Hyperglycemic Mouse Model after Birth with Low Birth Weight

  2024cites this paper
• Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation

  2024cites this paper
• Prader-Willi syndrome in a large sample from Spain: general features, obesity and regular use of psychotropic medication.

  2024cites this paper
• Measured Resting Energy Expenditure by Indirect Calorimetry and Energy Intake in Long-Term Growth Hormone-Treated Children with PWS

  2024cites this paper
• The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome

  2024cites this paper
• Growth hormone treatment in children with Prader–Willi syndrome: safety and effectiveness data from the PATRO Children study

  2024cites this paper
• The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature

  2024cites this paper
• Thyroid hormone levels in children with Prader-Willi Syndrome: A randomized controlled Growth Hormone (GH)-trial and 10-year GH study.

  2024cites this paper
• Lean body mass in boys with Prader-Willi syndrome increases normally during spontaneous and induced puberty.

  2023cites this paper
• Increased IGFBP proteolysis, IGF-I bioavailability and pappalysin levels in children with Prader-Willi syndrome.

  2023cites this paper
• Lebensqualität von kleinwüchsigen Kindern und Jugendlichen und Wachstumshormontherapie

  2023cites this paper
• Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review

  2023influential citation
• Cognitive function during 3 years of growth hormone in previously GH-treated young adults with PWS.

  2023cites this paper
• A Personalized Approach to Determining the Caloric Needs of Children with Prader–Willi Syndrome Treated with Growth Hormone

  2023cites this paper
• Schaaf-Yang Syndrome: Clinical Phenotype and Effects of 4 years of Growth Hormone Treatment

  2023cites this paper
• Acute stress response of the HPA-axis in children with Prader-Willi syndrome: new insights and consequences for clinical practice

  2023cites this paper
• The Effects of 5 Years of Growth Hormone Treatment on Growth and Body Composition in Patients with Temple Syndrome

  2023cites this paper
• Computer-aided facial analysis as a tool to identify patients with Silver–Russell syndrome and Prader–Willi syndrome

  2023cites this paper
• High levels of LIGHT/TNFSF14 in patients with Prader–Willi syndrome

  2023cites this paper
• Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome

  2023cites this paper
• Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome

  2022cites this paper
• Prader–Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach

  2022cites this paper
• Atypical 15q11.2-q13 Deletions and the Prader-Willi Phenotype

  2022cites this paper
• Genetic subtypes and phenotypic characteristics of 110 patients with Prader-Willi syndrome

  2022cites this paper
• Progression of Obstructive Sleep Apnea Syndrome in Pediatric Patients with Prader–Willi Syndrome

  2022cites this paper
• Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China

  2022cites this paper
• Long-Term Growth Hormone Treatment of Children with PWS: The Earlier the Start, the Better the Outcomes?

  2022cites this paper
• Free Insulin-like Growth Factor (IGF)-I in Children with PWS

  2022cites this paper
• Secondary diabetes mellitus in Prader-Willi syndrome

  2021cites this paper
• Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome

  2021cites this paper
• Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome

  2021cites this paper
• Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study

  2021cites this paper
• Prader-Willi syndrome: Hormone therapies.

  2021cites this paper
• Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis

  2021cites this paper
• Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader–Willi Syndrome

  2021cites this paper
• Growth Restriction and Genomic Imprinting-Overlapping Phenotypes Support the Concept of an Imprinting Network

  2021cites this paper
• Obesity in Prader–Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches

  2021cites this paper
• Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the Global Prader-Willi Syndrome Registry

  2021cites this paper
• Prader–Willi Syndrome and Hypogonadism: A Review Article

  2021cites this paper
• Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction.

  2021cites this paper
• Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

  2020cites this paper
• Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.

  2020cites this paper
• Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin

  2020cites this paper
• Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy

  2020cites this paper
• Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome

  2020cites this paper
• Variability and change over time of weight and BMI among adolescents and adults with Prader-Willi syndrome: a 6-month text-based observational study

  2020cites this paper
• Three years of growth hormone treatment in young adults with Prader‐Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome

  2020cites this paper
• Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition

  2020cites this paper
• Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in Relation to Growth Hormone Therapy Onset

  2020cites this paper
• Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome

  2020cites this paper
• Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment.

  2019cites this paper
• Growth hormone therapy in children; research and practice - A review.

  2019cites this paper
• Genetic Syndromes Presenting in Childhood Affecting Hypothalamic Function

  2019cites this paper
• Sleep-related breathing disorders in young adults with Prader-Willi syndrome: a placebo-controlled, cross-over GH trial.

  2019cites this paper
• Prader- Willi syndrome: An uptodate on endocrine and metabolic complications

  2019cites this paper
• Requirements for improving health and well‐being of children with Prader‐Willi syndrome and their families

  2019cites this paper
• Evidence for Accelerated Biological Aging in Young Adults with Prader–Willi Syndrome

  2019cites this paper
• Prader Willi syndrome: endocrine updates and new medical therapies.

  2019cites this paper
• Disorders of Breathing During Sleep

  2019cites this paper
• Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome

  2019cites this paper
• Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome

  2018cites this paper
• [Neuropsychiatric aspects of Prader-Willi syndrome – a review].

  2018cites this paper
• Bone mineral density in young adults with Prader‐Willi syndrome: A randomized, placebo‐controlled, crossover GH trial

  2018cites this paper
• PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO DO? - A REVIEW

  2018cites this paper
• Obesity management in Prader–Willi syndrome: current perspectives

  2018cites this paper
• Impacts on Learning and Development

  2018cites this paper
• Ghrelin Axis Reveals the Interacting Influence of Central Obesity and Hypertension

  2018cites this paper
• Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome.

  2018cites this paper
• Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children With Prader-Willi Syndrome

  2018cites this paper
• EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME – OUR FIRST EXPERIENCES

  2018cites this paper
• Suivi à 4 ans de la cohorte d'enfants atteints d'un syndrome de Prader-Willi traités par Ocytocine en période néonatale

  2018cites this paper
• Role of ghrelin in metabolic and muscle disorders

  2018cites this paper
• The Role of Radiology in the Diagnosis of Skeletal Dysplasias

  2018cites this paper
• Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.

  2017cites this paper
• Review of Prader-Willi syndrome: the endocrine approach.

  2017cites this paper
• Prevalence and risk factors for type 2 diabetes mellitus with Prader–Willi syndrome: a single center experience

  2017cites this paper
• Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database

  2017influential citation
• Metabolic health profile in young adults with Prader–Willi syndrome: results of a 2‐year randomized, placebo‐controlled, crossover GH trial

  2017cites this paper
• Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

  2017cites this paper
• Prader-Willi Syndrome

  2017cites this paper
• Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome

  2017cites this paper
• New Treatment Perspectives in Prader-Willi syndrome

  2016cites this paper
• The Central Role of Etiology in Science and Practice in Intellectual Disability

  2016cites this paper
• Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.

  2016cites this paper
• Growth hormone therapy for Prader–willi syndrome: challenges and solutions

  2016cites this paper
• Obesity and Growth Hormone Secretion

  2016cites this paper
• Early treatment with rhGH in patients with Prader-Willi syndrome results in improved height with no respiratory adverse effects

  2016cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature.

  2016cites this paper
• Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial.

  2016cites this paper
• OBESIDAD INFANTIL, NUEVO RETO MUNDIAL DE MALNUTRICIÓN EN LA ACTUALIDAD

  2016cites this paper
• Sequelae of GH Treatment in Children with PWS.

  2016cites this paper
• Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial

  2016cites this paper
• Acylated and unacylated ghrelin during OGTT in Prader‐Willi syndrome: support for normal response to food intake

  2016cites this paper
• Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.

  2016cites this paper
• Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.

  2016cites this paper